DiabetesMar 18, 2026
Bydureon (exenatide extended-release) can drop HbA1c by roughly 1.3 to 1.6 percentage points with a single weekly injection. That's a meaningful reduction for adults with type 2 diabetes who aren't getting enough from diet, exercise, and oral medications. But here's the tension worth understanding: head-to-head data show it's slightly less potent on both blood sugar and weight than liraglutide or semaglutide, two GLP-1 receptor agonists that now dominate the conversation.
So where does that leave Bydureon? Still effective, still convenient, but no longer the frontrunner. Whether it makes sense for you depends on what you're prioritizing and what trade-offs you're willing to accept.
Digestive DisordersMar 18, 2026
You've probably heard it before, maybe from a parent or grandparent: "Drink some milk, it'll settle your stomach." It feels intuitive. Milk is cool, creamy, and coats your throat on the way down. But when researchers actually put this old advice to the test, they found milk is not a reliable remedy for heartburn, and for some people, it can actively make reflux worse.
Immune SystemMar 18, 2026
For most people, there is almost nothing you need to avoid after a flu shot. The major guidelines from the CDC's Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) focus heavily on who should not get the vaccine in the first place and what precautions to take before vaccination. They do not include a list of post-shot lifestyle restrictions. The real "things to avoid" apply to a small group of people with specific medical histories, and those decisions should be made with a doctor before the needle ever goes in.
Kidney HealthMar 18, 2026
Sodium polystyrene sulfonate, commonly sold as Kayexalate, has been prescribed for decades to bring down high potassium levels, especially in people with kidney disease. Yet the evidence supporting it is surprisingly thin, and the potential harms are anything but trivial. In a systematic review of gastrointestinal injury cases, roughly one in three patients with serious bowel damage from this drug died. That is not a footnote. It is the central tension of a medication still widely used in hospitals and clinics today.
The core problem is a mismatch between expectation and reality. Patients and even some clinicians treat SPS as though it is a reliable, fast-acting fix for dangerous potassium levels. The research tells a different story: modest potassium reductions, an onset measured in hours to days, and a risk profile that includes bowel necrosis, heart failure, and interference with other medications you may be taking at the same time.
Antifungal TreatmentsMar 18, 2026
Most people prescribed nystatin for oral thrush get the suspension, that yellow liquid you swish around and swallow. But the research consistently shows that lozenges and pastilles outperform the suspension, and that how long you use nystatin matters just as much as which form you choose. If you have been swishing for a few days without results, the problem might not be the drug. It might be the delivery method.
Oral nystatin is a topical antifungal, meaning it works right where you put it rather than traveling through your bloodstream. It is not absorbed from the GI tract at all. That is both its biggest advantage (very few systemic side effects) and its limitation (it only works while it is in contact with the infection).
Blood HealthMar 18, 2026
Phytonadione, the main dietary form of vitamin K, is one of those drugs that looks straightforward on paper but behaves unpredictably in practice. It reliably reverses warfarin-related bleeding, yet in chronic liver disease, where clotting is clearly impaired, it does essentially nothing. And in critically ill children with septic shock, it normalizes clotting in fewer than half. Where and how phytonadione is used matters enormously, and the assumptions people make about it don't always hold up.
Phytonadione is FDA-approved for a specific set of conditions: reversing the effects of warfarin and other coumarin anticoagulants, treating hypoprothrombinemia caused by antibiotics, correcting vitamin K deficiency from malabsorption, and preventing or treating vitamin K-deficiency bleeding (VKDB) in newborns. Outside of those indications, the evidence gets thin fast.
PCOSMar 18, 2026
Letrozole was designed to treat breast cancer. But in head-to-head comparisons against clomiphene, the drug that dominated fertility treatment for over 50 years, letrozole produced higher ovulation rates, higher pregnancy rates, and more live births in women with PCOS. That shift was significant enough for international guidelines to now recommend letrozole as the first-line medication for ovulation induction in PCOS.
What makes this especially notable is that letrozole isn't just more effective in key populations. It also tends to produce single-follicle ovulation rather than multiple follicles, which translates to fewer twins and triplets. For anyone weighing fertility treatment options, that combination of better outcomes with lower risk of multiples is worth understanding.
Thyroid HealthMar 18, 2026
The vast majority of Synthroid side effects don't come from levothyroxine itself. They come from getting too much or too little of it. Levothyroxine has what pharmacologists call a narrow therapeutic index, meaning small dose changes can tip you from feeling fine into feeling terrible in either direction. That's not a flaw of the medication. It's a reality of how precisely thyroid hormone levels need to be managed.
This distinction matters because it shifts the conversation from "is this drug safe?" to "is my dose right?" And those are very different problems with very different solutions.
CreatineMar 18, 2026
A 21-day trial that directly compared creatine in a gelled candy form against creatine powder found zero differences in strength gains or fat-free mass. Both forms beat placebo. Your muscles don't care what the creatine arrived in. They care how much showed up.
That finding holds across broader reviews, too. When the dose of actual creatine is matched, no delivery format, and no "novel" creatine formulation, has ever consistently outperformed plain creatine monohydrate powder. The real question with gummies isn't whether they work. It's whether they make it quietly harder to take enough.
AsthmaMar 18, 2026
There is a dangerous assumption baked into how many people think about asthma: that if your disease is classified as mild, a serious attack is unlikely. The research tells a different story. Between 18% and 22% of people with mild asthma report a severe exacerbation within a single year, and a significant share of emergency department visits for asthma come from people carrying that "mild" label. An asthma exacerbation, the clinical term for those acute episodes of worsening breathlessness, wheezing, cough, and chest tightness, can be life-threatening regardless of where you fall on the severity spectrum.
These attacks are not just scary in the moment. They drive most of asthma's burden on health, finances, and daily quality of life, and they are now considered a core measure of both asthma severity and whether treatment is actually working.
Blood TestsMar 18, 2026
Your body's iron transport protein, transferrin, works like a shuttle with a fixed number of seats. Normally, only about one-third of those seats are filled with iron, leaving a large reserve of empty spots. The UIBC blood test counts those empty spots. When a lot of seats are open, your iron stores are running low. When almost every seat is taken, you may have too much iron or an inflammatory condition masking the picture.
What makes UIBC genuinely useful is its sensitivity to early iron depletion. Research shows UIBC is more accurate than transferrin saturation for detecting "empty" iron stores, and in some cases outperforms soluble transferrin receptor, particularly in women without inflammation and in large outpatient populations. It is not a standalone test, but it fills a gap that other iron markers can miss.
Pain ManagementMar 18, 2026
Pregabalin (brand name Lyrica) generally relieves neuropathic pain more quickly and slightly more effectively than gabapentin across multiple systematic reviews and meta-analyses. But that speed comes at a cost: more central nervous system side effects, a higher potential for misuse, and a bigger price tag per pill. The real question isn't which drug is "better." It's which tradeoff makes sense for your specific situation.
Both drugs are gabapentinoids, meaning they act on similar receptors in the nervous system. They're prescribed for overlapping conditions: postherpetic neuralgia (nerve pain after shingles), diabetic neuropathy, spinal cord injury pain, sciatica, and failed back surgery syndrome. But they are not interchangeable. Their differences in potency, how the body absorbs them, side-effect profiles, and cost create meaningfully different experiences for the people taking them.
StressMar 18, 2026
Most ashwagandha research studies capsules filled with standardized extracts, not the earthy cup of tea you might be brewing at home. But there's one detail buried in the science that makes the tea form genuinely interesting: water-based preparations capture triethylene glycol, a compound linked to non-REM sleep promotion in animal studies. Alcohol-rich withanolide extracts, the kind typically packed into supplement capsules, did not promote sleep in mice.
That distinction matters if sleep is the reason you're reaching for ashwagandha. It also introduces the central tension with ashwagandha tea: the traditional preparation might have a unique edge for sleep, but nearly all the clinical evidence we have comes from a different form entirely.
Women's HealthMar 18, 2026
Among all the reversible non hormonal birth control methods available today, only one qualifies as highly effective and long-acting: the copper IUD. Everything else in the non-hormonal category either depends heavily on how consistently you use it, works best paired with something else, or is permanent. That's a surprisingly narrow field for anyone trying to avoid hormones while also avoiding pregnancy.
The good news is there's a real research pipeline behind new non-hormonal options, including a male pill candidate already in early human trials. But none of those are available yet. So if you're weighing your current choices, here's what the evidence actually supports.
Autoimmune DiseasesMar 18, 2026
A rash isn't always just a rash. Many autoimmune and autoinflammatory diseases first announce themselves through the skin, sometimes well before internal organs show signs of trouble. Because skin is visible and easy to examine, certain rash patterns act as early warning signals, pointing toward specific systemic diseases and guiding doctors toward the right tests and treatment.
That makes recognizing these patterns genuinely useful. A persistent, photosensitive, or unusually shaped rash isn't something to shrug off or cover with hydrocortisone indefinitely. It may be the earliest, most accessible clue to something happening deeper inside.
InfectionsMar 18, 2026
Nystatin powder has been fighting Candida infections for a long time, and the evidence says it's still pulling its weight. In one striking example, classic topical nystatin powder at 6,000,000 units per gram eradicated severe angioinvasive fungal infections in burn wounds across 4 patients, clearing both superficial and deep disease without impairing wound healing. That's a drug applied directly to some of the most vulnerable tissue imaginable, doing its job and getting out of the way.
The reason nystatin stays relevant is also the reason it frustrates researchers: it barely absorbs into anything. Your gut doesn't take it up. Your skin doesn't take it up. That makes systemic toxicity very low, but it also means the powder itself dissolves poorly in water, doesn't penetrate deeply, and needs frequent reapplication. Modern pharmaceutical science is trying to solve exactly that problem.
Cardiovascular HealthMar 18, 2026
Autopsy and imaging studies find atherosclerotic lesions in the thoracic aorta in the majority of adults. Most of them had no idea anything was building up. Atherosclerosis of the aorta, the progressive accumulation of fatty, inflammatory plaque inside the wall of the body's largest artery, is one of the most common vascular conditions in existence. It is also one of the quietest.
That silence is the problem. By the time aortic atherosclerosis causes symptoms, it has often already contributed to a stroke, an aneurysm, or a clot that traveled somewhere it shouldn't. Understanding where this disease starts, how it progresses, and what actually drives it gives you a real chance to intervene before it reaches that point.
CancerMar 18, 2026
For decades, scientists have dreamed of a future where we could outwit cancer not by poisoning or carving it out, but by rewriting the genetic script it follows. That future is no longer science fiction. Gene therapy, which involves delivering carefully selected genetic material to counteract or kill cancer cells, is now a regular fixture in labs and clinical trials. But a new, more ambitious question is emerging: could gene therapy not just treat cancer, but help us live longer, healthier lives by preventing it in the first place?
In other words, how close are we to making gene therapy a safe and reliable tool for extending our healthspan—the portion of life spent in good health, free from chronic disease? The answer, like much of biology, is layered. There is real promise. However, these are accompanied by frustrating roadblocks and safety concerns that must be overcome before gene therapy makes the leap from treatment to prevention.
Skin HealthMar 18, 2026
The nose is the single most common site on the face for non-melanoma skin cancer. It protrudes, it catches sun year-round, and its complex anatomy makes both removal and repair a challenge. But the research is clear on what determines whether nasal skin cancer comes back: clean surgical margins. When surgeons achieve clear margins, recurrence sits around 6%. With positive (incomplete) margins, it climbs to roughly 24%.
That fourfold gap makes the surgical approach one of the most consequential decisions in treatment, sometimes more so than the specific type of cancer itself.
CortisolMar 18, 2026
Almost any meal raises your cortisol. That is the blunt, slightly inconvenient finding from controlled feeding studies: carbohydrate, protein, and fat each triggered a cortisol increase of roughly 90 nmol/L, lasting one to three hours in both lean and obese men. The spike comes from two routes at once, direct adrenal secretion and the liver regenerating cortisol on its own.
So the question isn't really which magical "cortisol food" to avoid. It's which eating patterns push that normal, transient bump into something your body has to deal with repeatedly, and whether certain meals hit harder than others. The research points to three clear amplifiers.
